Please ensure Javascript is enabled for purposes of website accessibility
Search
Accessibility Menu
Geron Stock Quote

Geron (NASDAQ: GERN)

$4.29
(-7.1%)
-$0.33
Price as of July 24, 2024, 4:00 p.m. ET

Geron Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
GERN +52.48% +294.87% +31.61% -35%
S&P +21.98% +84.97% +13.09% +768%

Geron Company Info

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

News & Analysis

The Fool has written over 300 articles on Geron.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.